Menu

Dulaglutide

Brand namesTrulicity

Dulaglutide (Trulicity) is a once-weekly GLP-1 injection for type 2 diabetes that also lowers heart attack and stroke risk. Dosing and side effects.

Medically reviewed by Michael A. Zimmer, MD, MACPUpdated 8 min read

About Dulaglutide

Dulaglutide is a glp-1 receptor agonist also known by the brand name Trulicity. It is primarily used for Type 2 diabetes in adults and children 10 years and older, with diet and exercise and Lowering the risk of heart attack, stroke and cardiovascular death in adults with type 2 diabetes who have heart disease or several cardiovascular risk factors (Trulicity label). Dulaglutide is available in trulicity single-dose prefilled pens: 0.75 mg, 1.5 mg, 3 mg and 4.5 mg, each in 0.5 ml, the needle is hidden and already attached; each pen is used once and discarded, and store in the refrigerator; a pen may be kept at room temperature (below 86°f) for up to 14 days in total form. Healthcare providers commonly prescribe Dulaglutide for conditions including Diabetes Mellitus, Coronary Artery Disease (CAD), and Obesity.

Dulaglutide at a Glance

Brand names
Trulicity
Drug class
GLP-1 Receptor Agonist
Pregnancy category
Use in pregnancy only if the potential benefit justifies the potential risk to the baby; there is limited human data, and animal studies showed harm. Tell your clinician if you are pregnant or planning a pregnancy, because blood sugar control still matters and other treatments such as insulin are usually preferred. It is not known whether dulaglutide passes into breast milk.
Available forms
Trulicity single-dose prefilled pens: 0.75 mg, 1.5 mg, 3 mg and 4.5 mg, each in 0.5 mL, The needle is hidden and already attached; each pen is used once and discarded, Store in the refrigerator; a pen may be kept at room temperature (below 86°F) for up to 14 days in total
Therapeutic categories
Diabetes, GLP-1 Agonists, Endocrine
Conditions treated
3 related conditions on this site

What Dulaglutide Is Used For

  • Type 2 diabetes in adults and children 10 years and older, with diet and exercise
  • Lowering the risk of heart attack, stroke and cardiovascular death in adults with type 2 diabetes who have heart disease or several cardiovascular risk factors (Trulicity label)

Dosage Quick Reference

These are general dosage guidelines for Dulaglutide. Your doctor will determine the appropriate dose for your specific situation.

StepWeekly DoseWhen to Move Up
Start (adults and children 10 and older)0.75 mg under the skin once weeklyAfter 4 weeks, if more blood sugar control is needed
Step 21.5 mg once weekly (the maximum dose for children)After at least 4 weeks
Step 3 (adults)3 mg once weeklyAfter at least 4 weeks
Maximum (adults)4.5 mg once weeklyHighest recommended dose
Missed doseTake it if at least 3 days (72 hours) remain before the next scheduled doseIf fewer than 3 days remain, skip it and take the next dose on schedule

Side Effects

Common side effects may include:

• Nausea, especially in the first weeks and after a dose increase • Diarrhea • Vomiting • Abdominal pain • Decreased appetite • Indigestion • Fatigue

Serious side effects (seek immediate medical attention):

• Severe stomach pain that may spread to the back, with or without vomiting (possible pancreatitis) • Pain in the upper right abdomen, fever or yellow skin or eyes (possible gallbladder disease) • A lump or swelling in the neck, trouble swallowing or persistent hoarseness • Ongoing vomiting or diarrhea with dizziness or little urine (dehydration and kidney injury) • Swelling of the face, lips or throat, or trouble breathing (allergic reaction) • Changes in vision • Low blood sugar when taken with insulin or a sulfonylurea

See also: Drug Interactions ↓

Drug Interactions

Dulaglutide is broken down like other proteins and does not rely on CYP450 liver enzymes. Its interactions come from slowed stomach emptying and from added blood sugar lowering.

  • Insulin and sulfonylureas (for example glipizide): Higher risk of low blood sugar. The insulin or sulfonylurea dose is often lowered when dulaglutide starts.
  • Oral medicines with a narrow safety margin (for example warfarin): Slower stomach emptying can change how quickly pills are absorbed; extra monitoring may be needed after starting or changing the dose.
  • Other GLP-1 medicines (for example semaglutide, liraglutide or tirzepatide): Not used together.
  • DPP-4 inhibitors (for example sitagliptin): Work through the same hormone system and add little benefit, so they are usually stopped.
  • Alcohol: Can worsen nausea and raise the risk of low blood sugar in people on insulin or a sulfonylurea.

See also: Questions to Ask Your Doctor ↓

Key Considerations

Known drug interactions

Dulaglutide has documented interactions with other medications, supplements, and certain foods. Review the Drug Interactions section below and tell your healthcare provider about every medication you take, including over-the-counter products. Jump to section →

Multiple forms available

Dulaglutide comes in more than one form (Trulicity single-dose prefilled pens: 0.75 mg, 1.5 mg, 3 mg and 4.5 mg, each in 0.5 mL, The needle is hidden and already attached; each pen is used once and discarded, Store in the refrigerator; a pen may be kept at room temperature (below 86°F) for up to 14 days in total). The right form for you depends on your condition, ease of use, and your provider's recommendation.

Additional Information

Dulaglutide is a once-weekly injection sold as Trulicity. FDA approved it in 2014 for type 2 diabetes, and it later became one of the GLP-1 medicines proven to lower the risk of heart attack and stroke. It is given with a single-use pen that hides the needle, which made it a popular first injectable for people who were nervous about shots. It is approved for diabetes only; it is not a weight loss medicine, although many people lose a modest amount of weight while taking it.

How Dulaglutide Works

Dulaglutide copies the action of GLP-1, a gut hormone released after meals. It helps the pancreas release insulin when blood sugar is high, lowers glucagon (a hormone that raises blood sugar), slows stomach emptying and reduces appetite. Because the insulin effect depends on glucose, dulaglutide rarely causes low blood sugar when used on its own or with metformin.

The medicine is a GLP-1 molecule fused to part of a human antibody. That larger structure protects it from being broken down quickly, giving it a half-life of about five days, so one dose lasts a week.

FDA-Approved Uses

Type 2 Diabetes in Adults and Children

Dulaglutide is approved, alongside diet and exercise, to improve blood sugar in adults and in children 10 years and older with type 2 diabetes. It can be used alone or with metformin, SGLT2 inhibitors such as empagliflozin, sulfonylureas and insulin. In the trials behind its approval, the 0.75 mg and 1.5 mg doses lowered A1c by roughly 0.7 to 1.6 percentage points, depending on the starting A1c and the other medicines being taken. It is not used for type 1 diabetes.

Lowering Heart Attack and Stroke Risk

In 2020, FDA added an indication to reduce major cardiovascular events in adults with type 2 diabetes who have established heart disease or multiple cardiovascular risk factors. The approval was based on the REWIND trial, published in The Lancet, which followed about 9,900 adults for a median of 5.4 years. Heart attack, stroke or cardiovascular death occurred about 12 percent less often with dulaglutide than with placebo. Most participants did not have a prior heart attack or stroke, which is why the label covers people at high risk as well as those with known coronary artery disease.

Dosing and How to Take It

Everyone starts at 0.75 mg once a week. After four weeks, the dose can go up to 1.5 mg if blood sugar is still above goal. Adults who need more can move to 3 mg and then 4.5 mg, staying at least four weeks at each step, as described in the Trulicity label. For children, 1.5 mg is the highest dose.

Inject it on the same day each week, at any time of day, with or without food, into the abdomen, thigh or upper arm, and rotate the site. If you miss a dose and at least three days remain before the next one, take it. If fewer than three days remain, skip it and return to your regular day.

Unopened pens belong in the refrigerator. A pen can stay at room temperature for up to 14 days in total, which helps with travel, but it should never be frozen.

Side Effects

Stomach symptoms are the most common. In placebo-controlled trials, about one in five people on the 1.5 mg dose had nausea, and about one in eight had diarrhea or vomiting. These effects are usually mild to moderate, appear in the first weeks, and ease as the body adjusts. Eating smaller meals, stopping when full and limiting greasy food help. Our guide to managing GLP-1 side effects has more practical tips.

Boxed Warning and Serious Risks

Dulaglutide carries a boxed warning for thyroid C-cell tumors, based on rodent studies; whether it causes these tumors in people is unknown. It is not used by anyone with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN 2).

Other serious risks listed on the label include pancreatitis, gallbladder disease, kidney injury from dehydration after vomiting or diarrhea, severe allergic reactions and worsening of diabetic eye disease in people who already have retinopathy. It is not recommended for people with severe gastroparesis. Because it slows stomach emptying, tell your surgeon or anesthesiologist that you take it before any procedure with sedation.

Dulaglutide Compared With Newer GLP-1 Medicines

Dulaglutide was once the most prescribed GLP-1 medicine in the United States. Newer options generally lower A1c and weight more. In head-to-head studies, semaglutide (Ozempic) lowered A1c and weight more than dulaglutide at comparable dose levels, and tirzepatide (Mounjaro) more still. The higher 3 mg and 4.5 mg doses of dulaglutide, added in 2020, narrowed that gap somewhat.

Dulaglutide still has real strengths: a proven heart benefit, no dose change needed for kidney disease, an easy pen, and a long safety record. For someone whose diabetes is well controlled on it and who tolerates it, there is often no reason to switch. If weight loss is a main goal, or A1c stays above target at the highest dose, we talk about moving to another medicine in the class.

Monitoring and Follow-Up

We check A1c about every three months until it is at goal, then every six months, along with kidney function and cholesterol at our in-office lab. If you take insulin or a sulfonylurea, we review home glucose readings closely in the first weeks, since those doses often need to come down. People with diabetic retinopathy should stay current with dilated eye exams, especially when blood sugar improves quickly.

Getting Started in St. Petersburg

Dulaglutide is one of several GLP-1 options we prescribe for type 2 diabetes. Our physicians choose among them based on your A1c, heart and kidney health, weight goals and insurance coverage, and our GLP-1 medication program explains how the choices compare. To review your diabetes treatment, schedule a visit.

Frequently Asked Questions

Trulicity is a brand name for dulaglutide.
Dulaglutide is sold under the brand name Trulicity.
No. Trulicity (dulaglutide) is FDA-approved only for type 2 diabetes and for lowering cardiovascular risk in adults with type 2 diabetes. Many people lose a few pounds on it because it reduces appetite, but the average weight loss is smaller than with semaglutide or tirzepatide, which have separate brands approved for weight management.
For adults, the maximum recommended dose is 4.5 mg once weekly. Treatment starts at 0.75 mg and can rise to 1.5 mg, 3 mg and then 4.5 mg, with at least four weeks at each step and only if more blood sugar control is needed. For children 10 and older, the maximum is 1.5 mg weekly.
Both are once-weekly GLP-1 injections for type 2 diabetes with proven heart benefits. In a head-to-head trial, semaglutide (Ozempic) lowered A1c and body weight more than dulaglutide (Trulicity) at comparable doses. Trulicity uses a single-use pen with a hidden, pre-attached needle, which some people find simpler. Coverage and tolerance often decide the choice.
Usually, yes. The Trulicity label recommends no dose adjustment for reduced kidney function, including end-stage kidney disease. The main caution is dehydration: ongoing vomiting or diarrhea can injure the kidneys, so drink fluids and call us if stomach side effects are severe or do not settle.

Questions to Ask Your Doctor About Dulaglutide

Consider discussing these topics at your next appointment:

  • Is dulaglutide still the best GLP-1 choice for me, or would a newer option fit my goals better?
  • What A1c are we aiming for, and when would we raise the dose?
  • Should my insulin or sulfonylurea dose be lowered when I start?
  • Do I need a dilated eye exam before my blood sugar comes down quickly?
  • What should I do about dulaglutide before surgery or a colonoscopy?

Questions About Dulaglutide?

Your primary care doctor in St. Petersburg can review Dulaglutide alongside everything else you take, check for interactions, and adjust your plan as your health changes.

Request an appointment

Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.